A novel pathogenic mutation in FBN2 associated with congenital contractural arachnodactyly for preimplantation genetic diagnosis
-
Jiaxin Li and Yuqian Wang contributed equally to this work.
-
Fig. 1. Verification of the pathogenic mutation (FBN2, c.3719G > A) of this CCA family.A: Pedigree of this CCA family. Filled symbols marked with red numbers represent individuals affected by CCA; open symbols marked with black numbers represent wild-type individuals. Circles and squares indicate females and males, respectively. The couple indicated by red asterisks asked for PGD treatment. B: Sanger sequencing detection of FBN1 mutation (c.698G > A) for the entire family. Red G/A and arrow marked individuals carry this heterozygous mutation. Orange boxes highlight that phenotypes and genotypes are at odds.C: Pathogenicity prediction of FBN2, c.3719G > A by MutationTaster-2. This variant was not found in ExAC or 1000G, and it is highly possible that the mutation causes disease.D: Pathogenicity prediction of FBN2, c.3719G > A by PolyPhen-2. This mutation was predicted to be damaging with a score of 0.996 (score ranges from 0 to 1, and the higher the score, the higher the pathogenicity).E: Sanger sequencing detection of FBN2 mutation (c.3719G > A) for the entire family. Individuals marked with a red G/A and arrow carry this heterozygous mutation, and the mutation corresponds to the incidence in these families.F: Conservation analysis of 1240C and protein structure change after C1240Y. Modeled structures of cbEGF Domains 18 and 19 of the FBN2 protein were illustrated in the wild type and mutation. The wild-type and mutant sequences of cbEGF Domains 18 and 19 are provided in Supplementary data (supplementary file 1 and 2). cbEGF, calcium-binding epidermal growth factor–like; CCA, congenital contractural arachnodactyly; PGD, preimplantation genetic diagnosis.
-
[1] Adzhubei, I., Jordan, D.M., Sunyaev, S.R., 2013. Predicting functional effect of hu-man missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. Chapter 7: Unit7.20. [2] Arteaga-Solis, E., Gayraud, B., Lee, S.Y., Shum, L., Sakai, L., Ramirez, F., 2001. Regulation of limb patterning by extracellular microfibrils. J. Cell Biol. 154, 275-281. [3] Belleh, S., Zhou, G., Wang, M., Der Kaloustian, V.M., Pagon, R.A., Godfrey, M., 2000. Two novel fibrillin-2 mutations in congenital contractural arachnodactyly. Am. J. Med. Genet. 92, 7-12. [4] Bitterman, A.D., Sponseller, P.D., 2017. Marfan syndrome: a clinical update. J. Am. Acad. Orthop. Surg. 25, 603-609. [5] Downing, A.K., Knott, V., Werner, J.M., Cardy, C.M., Campbell, I.D., Handford, P.A., 1996. Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 85, 597-605. [6] Frederic, M.Y., Monino, C., Marschall, C., Hamroun, D., Faivre, L., Jondeau, G., Klein, H.G., Neumann, L., Gautier, E., Binquet, C., Maslen, C., Godfrey, M., Gupta, P., Milewicz, D., Boileau, C., Claustres, M., Beroud, C., Collod-Beroud, G., 2009. The FBN2 gene: new mutations, locus-specific database (Universal Mutation Database FBN2), and genotype-phenotype correlations. Hum. Mutat. 30, 181-190. [7] Gupta, P.A., Putnam, E.A., Carmical, S.G., Kaitila, I., Steinmann, B., Child, A., Danesino, C., Metcalfe, K., Berry, S.A., Chen, E., Delorme, C,V,, Thong, M.K., Ades, L.C., Milewicz, D.M. (2002). Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype. Hum. Mutat. 19, 39-48. [8] Jones, J.L., Lane, J.E., Logan, J.J., Vanegas, M.E., 2002. Beals-hecht syndrome. South. Med. J. 95, 753-755. [9] Jurko, A., Krsiakova, J., Minarik, M., Tonhajzerova, I., 2013. Congenital contractural arachnodactyly (Beals-hecht syndrome): a rare connective tissue disorder. Wien. Klin. Wochenschr. 125, 288-290. [10] Lee, B., Godfrey, M., Vitale, E., Hori, H., Mattei, M.G., Sarfarazi, M., Tsipouras, P., Ramirez, F., Hollister, D.W., 1991. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 352, 330-334. [11] Liu, W., Zhao, N., Li, X.F., Wang, H., Sui, Y., Lu, Y.P., Feng, W.H., Ma, C., Han, W.T., Jiang, M., 2015. A novel FBN2 mutation in a Chinese family with congenital contractural arachnodactyly. FEBS Open Bio. 5, 163-166. [12] Maslen, C., Babcock, D., Raghunath, M., Steinmann, B., 1997. A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly. Am. J. Hum. Genet. 60, 1389-1398. [13] Matsumoto, T., Watanabe, A., Migita, M., Gocho, Y., Hayakawa, J., Ogawa, S., Shi-mada, T., Fukunaga, Y., 2006. Transient cardiomyopathy in a patient with con-genital contractural arachnodactyly (Beals syndrome). J. Nippon Med. Sch. 73, 285-288. [14] McClure, S.D., van de Velde, S., Fillman, R., Yandow, S., 2007. New finding of pro-trusio acetabuli in two families with congenital contractural arachnodactyly. A report of seven cases. J. Bone Joint Surg. Am. 89, 849-854. [15] Penner, A.S., Rock, M.J., Kielty, C.M., and Shipley, J.M. (2002). Microfibril-associated glycoprotein-2 interacts with fibrillin-1 and fibrillin-2 suggesting a role for MAGP-2 in elastic fiber assembly. J. Biol. Chem. 277, 35044-35049. [16] Schwarz, J.M., Cooper, D.N., Schuelke, M., Seelow, D., 2014. MutationTaster2: mutation prediction for the deep-sequencing age. Nat. Methods 11, 361-362. [17] Tuncbilek, E., Alanay, Y., 2006. Congenital contractural arachnodactyly (Beals syndrome). Orphanet. J. Rare Dis. 1, 20. [18] You, G., Zu, B., Wang, B., Wang, Z., Xu, Y., Fu, Q., 2017. Exome sequencing iden-tified a novel FBN2 mutation in a Chinese family with congenital contractural arachnodactyly. Int. J. Mol. Sci. 18, E626. -